170 related articles for article (PubMed ID: 28344259)
1. Effects of Particle Hydrophobicity, Surface Charge, Media pH Value and Complexation with Human Serum Albumin on Drug Release Behavior of Mitoxantrone-Loaded Pullulan Nanoparticles.
Tao X; Jin S; Wu D; Ling K; Yuan L; Lin P; Xie Y; Yang X
Nanomaterials (Basel); 2015 Dec; 6(1):. PubMed ID: 28344259
[TBL] [Abstract][Full Text] [Related]
2. Effect of pullulan nanoparticle surface charges on HSA complexation and drug release behavior of HSA-bound nanoparticles.
Tao X; Zhang Q; Ling K; Chen Y; Yang W; Gao F; Shi G
PLoS One; 2012; 7(11):e49304. PubMed ID: 23166632
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol-Modified Amino-Pullulan Nanoparticles as a Drug Carrier: Comparative Study of Cholesterol-Modified Carboxyethyl Pullulan and Pullulan Nanoparticles.
Tao X; Xie Y; Zhang Q; Qiu X; Yuan L; Wen Y; Li M; Yang X; Tao T; Xie M; Lv Y; Wang Q; Feng X
Nanomaterials (Basel); 2016 Sep; 6(9):. PubMed ID: 28335293
[TBL] [Abstract][Full Text] [Related]
4. Pullulan-Based Nanoparticle-HSA Complex Formation and Drug Release Influenced by Surface Charge.
Yuan L; Cao Y; Luo Q; Yang W; Wu X; Yang X; Wu D; Tan S; Qin G; Zhou J; Zeng Y; Chen X; Tao X; Zhang Q
Nanoscale Res Lett; 2018 Oct; 13(1):317. PubMed ID: 30306404
[TBL] [Abstract][Full Text] [Related]
5. Novel Delivery of Mitoxantrone with Hydrophobically Modified Pullulan Nanoparticles to Inhibit Bladder Cancer Cell and the Effect of Nano-drug Size on Inhibition Efficiency.
Tao X; Tao T; Wen Y; Yi J; He L; Huang Z; Nie Y; Yao X; Wang Y; He C; Yang X
Nanoscale Res Lett; 2018 Oct; 13(1):345. PubMed ID: 30377872
[TBL] [Abstract][Full Text] [Related]
6.
Huang RF; Guo Y; Yao C; Wu W; Ou L
Curr Drug Deliv; 2023; 20(10):1465-1473. PubMed ID: 36683375
[TBL] [Abstract][Full Text] [Related]
7. Self-assembled pH-sensitive cholesteryl pullulan nanogel as a protein delivery vehicle.
Morimoto N; Hirano S; Takahashi H; Loethen S; Thompson DH; Akiyoshi K
Biomacromolecules; 2013 Jan; 14(1):56-63. PubMed ID: 23215439
[TBL] [Abstract][Full Text] [Related]
8. Brain-Targeted Polysorbate 80-Emulsified Donepezil Drug-Loaded Nanoparticles for Neuroprotection.
Tao X; Mao S; Zhang Q; Yu H; Li Y; He X; Yang S; Zhang Z; Yi Z; Song Y; Feng X
Nanoscale Res Lett; 2021 Aug; 16(1):132. PubMed ID: 34406517
[TBL] [Abstract][Full Text] [Related]
9. A Study of Hydrophobically Modified Pullulan Nanoparticles with Different Hydrophobic Densities on the Effect of Anti-Colon Cancer Cell Efficiency.
Zhang Y; Jiang Q; Liu X; Peng L; Tang X; Li L; Ling X; Yang X; He C; Tao X; Hou D
J Biomed Nanotechnol; 2021 Oct; 17(10):1972-1983. PubMed ID: 34706797
[TBL] [Abstract][Full Text] [Related]
10. Pullulan-based nanoparticles as carriers for transmucosal protein delivery.
Dionísio M; Cordeiro C; Remuñán-López C; Seijo B; Rosa da Costa AM; Grenha A
Eur J Pharm Sci; 2013 Sep; 50(1):102-13. PubMed ID: 23624352
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of biotin modified cholesteryl pullulan as a novel anticancer drug carrier.
Yang W; Wang M; Ma L; Li H; Huang L
Carbohydr Polym; 2014 Jan; 99():720-7. PubMed ID: 24274563
[TBL] [Abstract][Full Text] [Related]
12. [Preparation of a hyaluronic acid modified bovine serum albumin nanoparticle and its anti-tumor effect].
Fang YW; Yin ZN
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):480-4, 502. PubMed ID: 21866630
[TBL] [Abstract][Full Text] [Related]
13. Single molecular mechanics of a cholesterol-bearing pullulan nanogel at the hydrophobic interfaces.
Lee I; Akiyoshi K
Biomaterials; 2004 Jul; 25(15):2911-8. PubMed ID: 14967522
[TBL] [Abstract][Full Text] [Related]
14. The preliminary evaluation on cholesterol-modified pullulan as a drug nanocarrier.
Shen S; Li H; Yang W
Drug Deliv; 2014 Nov; 21(7):501-8. PubMed ID: 24625263
[TBL] [Abstract][Full Text] [Related]
15. Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells.
Wu D; Chen Y; Wen S; Wen Y; Wang R; Zhang Q; Qin G; Yi H; Wu M; Lu L; Tao X; Deng X
Nanoscale Res Lett; 2019 Sep; 14(1):314. PubMed ID: 31520223
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib-Entrapped, Self-Assembled Pullulan-Stearic Acid Biopolymer-Derived Drug Delivery System to PLC/PRF/5 Hepatocellular Carcinoma Model.
Chirayil TJ; Kumar GSV
Int J Nanomedicine; 2022; 17():5099-5116. PubMed ID: 36340185
[TBL] [Abstract][Full Text] [Related]
17. Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: in vivo studies.
Cevher E; Salomon SK; Somavarapu S; Brocchini S; Alpar HO
J Microencapsul; 2015; 32(8):769-83. PubMed ID: 26480962
[TBL] [Abstract][Full Text] [Related]
18. Green Synthesized Silver Nanoparticle-Loaded Liposome-Based Nanoarchitectonics for Cancer Management: In Vitro Drug Release Analysis.
Jayachandran P; Ilango S; Suseela V; Nirmaladevi R; Shaik MR; Khan M; Khan M; Shaik B
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672725
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin.
Akiyoshi K; Kobayashi S; Shichibe S; Mix D; Baudys M; Kim SW; Sunamoto J
J Control Release; 1998 Aug; 54(3):313-20. PubMed ID: 9766251
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of fast dissolving pullulan films containing BCS class II drug nanoparticles for bioavailability enhancement.
Krull SM; Ma Z; Li M; Davé RN; Bilgili E
Drug Dev Ind Pharm; 2016; 42(7):1073-85. PubMed ID: 26567632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
